loadpatents
Patent applications and USPTO patent grants for STEIDL; Stefan.The latest application filed is for "anti-cd38 antibodies and pharmaceutical compositions thereof for the treatment of autoantibody-mediated autoimmune disease".
Patent | Date |
---|---|
Anti-cd38 Antibodies And Pharmaceutical Compositions Thereof For The Treatment Of Autoantibody-mediated Autoimmune Disease App 20220144965 - KLUNKER; Daniel ;   et al. | 2022-05-12 |
Anti-gm-csf Antibodies App 20210347879 - STEIDL; Stefan ;   et al. | 2021-11-11 |
Nucleic acid encoding anti-GM-CSF antibodies Grant 11,028,165 - Steidl , et al. June 8, 2 | 2021-06-08 |
Treatment For Rheumatoid Arthritis App 20210130451 - HARTLE; Stefan ;   et al. | 2021-05-06 |
Treatment for rheumatoid arthritis Grant 10,913,792 - Hartle , et al. February 9, 2 | 2021-02-09 |
Combinations And Uses Thereof App 20200353077 - AMERSDORFFER; Jutta ;   et al. | 2020-11-12 |
Combinations And Uses Thereof App 20200352975 - AMERSDORFFER; Jutta ;   et al. | 2020-11-12 |
Anti-gm-csf Antibodies App 20200024340 - Steidl; Stefan ;   et al. | 2020-01-23 |
Methods of treatment using anti-GM-CSF antibodies Grant 10,377,820 - Steidl , et al. A | 2019-08-13 |
Anti-mesothelin Antibodies And Uses Thereof App 20180258181 - KAHNERT; Antje ;   et al. | 2018-09-13 |
Method For The Treatment Of Pain And Osteoarthritis With C-fms Antagonists App 20180237531 - STEIDL; Stefan ;   et al. | 2018-08-23 |
Treatment For Rheumatoid Arthritis App 20180230208 - Hartle; Stefan ;   et al. | 2018-08-16 |
Method for treatment of osteoarthritis with C-Fms antagonists Grant 10,005,840 - Steidl , et al. June 26, 2 | 2018-06-26 |
Anti-GM-CSF antibodies Grant 9,751,939 - Steidl , et al. September 5, 2 | 2017-09-05 |
Anti-gm-csf Antibodies App 20170218061 - Steidl; Stefan ;   et al. | 2017-08-03 |
Use of c-Fms antagonists App 20160185867 - Steidl; Stefan ;   et al. | 2016-06-30 |
Use of M-CSF antibodies in the treatment of osteoarthritis or pain Grant 9,243,066 - Steidl , et al. January 26, 2 | 2016-01-26 |
Anti-mesothelin Antibodies And Uses Thereof App 20150259433 - KAHNERT; Antje ;   et al. | 2015-09-17 |
Treatment For Rheumatoid Arthritis App 20150246969 - Hartle; Stefan ;   et al. | 2015-09-03 |
Anti-mesothelin antibodies and uses thereof Grant 9,023,351 - Kahnert , et al. May 5, 2 | 2015-05-05 |
Combination Therapy With An Anti - Cd19 Antibody And A Nitrogen Mustard App 20140255427 - Amersdorffer; Jutta ;   et al. | 2014-09-11 |
Therapeutic Combinations Of Anti-cd20 And Anti-gm-csf Antibodies And Uses Thereof App 20140234298 - Steidl; Stefan | 2014-08-21 |
Combination therapy with an anti-CD19 antibody and a purine analog App 20140227277 - Amersdorffer; Jutta ;   et al. | 2014-08-14 |
Use of c-Fms antagonists App 20140205608 - Steidl; Stefan ;   et al. | 2014-07-24 |
Treatment For MTreatment For Multiple Sclerosis App 20120116059 - Steidl; Stefan ;   et al. | 2012-05-10 |
Generation And Profiling Of Fully Human Hucal Gold.rtm.-derived Therapeutic Antibodies Specific For Human Cd38 App 20120076782 - Tesar; Michael ;   et al. | 2012-03-29 |
Anti-alk1 Antibodies And Uses Thereof App 20110110944 - Steidl; Stefan ;   et al. | 2011-05-12 |
Anti-GM-CSF antibodies and uses therefor App 20110045000 - Steidl; Stefan ;   et al. | 2011-02-24 |
Anti-mesothelin Antibodies And Uses Thereof App 20110027268 - Kahnert; Antje ;   et al. | 2011-02-03 |
Anti-GM-CSF antibodies and uses therefor Grant 7,867,495 - Steidl , et al. January 11, 2 | 2011-01-11 |
Proteinaceous binding molecules comprising purification tags or inert variable domains App 20100291078 - Steidl; Stefan | 2010-11-18 |
Anti Ephb4 Antibodies And Antibody Fragments App 20090137002 - PETRUL; Heike ;   et al. | 2009-05-28 |
High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity App 20090081207 - MENRAD; ANDREAS ;   et al. | 2009-03-26 |
Anti-Gm-Csf Antibodies and Uses Therefor App 20090053213 - Steidl; Stefan ;   et al. | 2009-02-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.